The US pharmaceutical and biotech market is undergoing rapid transformation driven by shifting policy, evolving payer behaviors, and technological innovation.
In the next episode of the Simon-Kucher Better Market Access webinar series, we will explore significant trends shaping the US market access landscape in 2025 and beyond. Industry experts will share how leading pharmaceutical and biotech companies are adapting their operational approaches and long-term strategies to remain competitive, ensure access, and deliver value in an increasingly complex environment.
Key topics:
- Impact of the Inflation Reduction Act on lifecycle strategy and gross-to-net forecasting
- Increase in pharmacy and medical benefit management and impact on patient access and payer contracting strategies
- Acceleration of integration across the healthcare ecosystem, with payers, pharmacy benefit managers (PBMs), and providers consolidating and its impact on drug pricing, access, and distribution pathways
- Expansion of direct-to-consumer (DTC) channels, reshaping traditional patient engagement and brand loyalty strategies
- Emerging use cases for artificial intelligence and machine learning in optimizing market access strategy, forecasting, and payer, physician, and patient engagement
Event details:
Tuesday, July 15, 2025 | 10:00 -11:00 a.m. EDT; 4:00 – 5:00 p.m. CEST
This webinar is free of charge. Register now for insightful reflections from discussions with our US market access industry experts, actionable takeaways, and a forward-looking view on how to thrive in this evolving landscape.
